Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V710 vaccine trial in adults undergoing cardiothoracic surgery
2007-004018-15Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Staphylococcus aureus infection comparing V710 vaccine with Placebo (2 arms). Primary endpoint: Proportion of patients with S. aureus bacteremia and/or S. aureus deep sternal wound infection through postoperative Day 90. Started Nov 2007; status: terminated.
02
Drugs
V710
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on 2007-004018-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004018-15.